Literature DB >> 959097

Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.

W D Alexander, R T Wensley, G Price, M Hartog.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 959097      PMCID: PMC2496508          DOI: 10.1136/pgmj.52.607.251

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  13 in total

1.  FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS.

Authors:  N MACKAY; R HUME
Journal:  Scott Med J       Date:  1964-09       Impact factor: 0.729

2.  PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD.

Authors:  G R FEARNLEY; R CHAKRABARTI
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

3.  Clearing factor, fibrinolysis and blood lipids in diabetes mellitus.

Authors:  M A DENBOROUGH; B PATERSON
Journal:  Clin Sci       Date:  1962-12       Impact factor: 6.124

4.  The effects of chlorpropamide on intermittent claudication and fibrinolysis.

Authors:  M J TSAPOGAS; L T COTTON; P T FLUTE; J G MURRAY
Journal:  Lancet       Date:  1962-06-09       Impact factor: 79.321

5.  Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.

Authors:  G R FEARNLEY; R CHAKRABARTI; P R AVIS
Journal:  Br Med J       Date:  1963-04-06

6.  An improved plasma recalcified clotting test and its modification as a simple rapid heparin retarded clotting test.

Authors:  R D EASTHAM
Journal:  J Clin Pathol       Date:  1962-01       Impact factor: 3.411

7.  Effect of the sulphonylureas on fibrinolysis.

Authors:  G R FEARNLEY; R CHAKRABARTI; C T VINCENT
Journal:  Lancet       Date:  1960-09-17       Impact factor: 79.321

8.  Blood lipids, mucoproteins, and fibrinolytic activity in diabetic Indians and Africans in Natal. Possible relation to vascular complications.

Authors:  M HATHORN; T GILLMAN; G D CAMPBELL
Journal:  Lancet       Date:  1961-06-17       Impact factor: 79.321

9.  Reduction of blood fibrinolytic activity in diabetes mellitus by insulin.

Authors:  G R FEARNLEY; C T VINCENT; R CHAKRABARTI
Journal:  Lancet       Date:  1959-12-12       Impact factor: 79.321

10.  Evidence of an active fibrinolytic enzyme in the plasma of normal people with observations on inhibition associated with the presence of calcium.

Authors:  G R FEARNLEY; J M TWEED
Journal:  Clin Sci       Date:  1953-02       Impact factor: 6.124

View more
  1 in total

Review 1.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.